Eficacia de la atorvastatina en el infarto cerebral aterotrombótico agudo / Effectiveness of atorvastatin in acute atherothrombotic cerebral infartation

Introducción: Las enfermedades Cerebrovasculares constituyen un importante problema de salud a escala global y en Cuba ocupan la tercera causa de muerte y la primera causa de discapacidad. Objetivo: Evaluar el uso de atorvastatina en el infarto cerebral aterotrombótico agudo. Métodos: Se realizó un estudio prospectivo longitudinal en los pacientes que acudieron al cuerpo de guardia del Hospital Clínico Quirúrgico Julio Trigo López diagnosticados como infarto cerebral aterotrombótico agudo. De forma aleatoria y con previo consentimiento informado se les suministró una dosis de 0, 20 mg o 40 mg de atorvastatina. Se les realizó tomografía axial computarizada de cráneo, la cual fue repetida al tercer día y a los 30 días. Se determinó el valor de proteína C reactiva en el cuerpo de guardia, y a los 30 días fueron evaluados clínicamente de acuerdo a la escala de National Institute of Health Stroke Scale en cuerpo de guardia, diariamente durante su ingreso y 30 días después. Resultados: El tamaño del área infartada disminuyó un 19,4 por ciento con 40 mg de atorvastatina al igual que el valor de proteína C reactiva que se redujo en 16 mg/L. La evaluación clínica según la escala de National Institute of Health Stroke Scale mostró una reducción en más de 8 puntos de acuerdo a la dosis de atorvastatina empleada. Conclusiones: Se demostró la eficacia de la atorvastatina por la disminución del área infartada, la reducción de los valores de proteína C reactiva y la evolución clínica favorable. Todos estos factores fueron directamente proporcional a la dosis de atorvastatina empleada(AU)

Introduction: Cererovascular diseases represent an important health problem worldwide and in Cuba they rank the third cause of death and the first cause of disability. Objective: To evaluate the use of astorvastin in acute atherotrombotic cerebral infactation. Methods: A longitudinal prospective study was carried out in patients who attended the emergency room of Julio Trigo López Surgical Clinical Hospital diagnosed with acute atherothrombotic cerebral infarction. Randomly and with prior informed consent, they were given a dose of 0, 20 mg or 40 mg of atorvastatin. Computerized axial tomography of the skull was performed, which was repeated on day 3 and day 30. The value of C-reactive protein in the emergency room was determined, and at day 30, they were clinically evaluated daily during admission and 30 days later, according to the scale of the National Institute of Health Stroke Scale in emergency room. Results: The size of the infarcted area decreased by 19.4 percent with 40 mg of atorvastatin, as well as the value of C-reactive protein, which decreased by 16 mg/L. The clinical evaluation according to the National Institute of Health Stroke Scale showed reduction of more than 8 points according to the dose of atorvastatin used. Conclusions: The efficacy of atorvastatin was demonstrated by the reduction of the infarcted area, the reduction of C-reactive protein values and the favorable clinical evolution. All of these factors were directly proportional to the dose of atorvastatin used(AU)

Tamaño del infarto cerebral aterotrombótico del territorio carotídeo según sus factores de riesgo / Size of the atherothrombotic cerebral infarction from carotid territory according to its risk factors

Introducción: La mayoría de los infartos cerebrales aterotrombóticos son debidos a aterosclerosis extracraneal y a los factores de riesgo que lo condicionan. Objetivo: Caracterizar a pacientes con ictus aterotrombótico de territorio anterior según tamaño, sexo y factores de riesgo aterotrombótico. Métodos: Se realizó un estudio transversal a 63 pacientes que acudieron al Hospital Militar Central "Dr. Carlos J. Finlay" con diagnóstico de infarto cerebral aterotrombótico reciente de territorio carotídeo, a los que se les realizó tomografía de cráneo simple, entre los años 2011 y 2013. Resultados: Predominaron los infartos grandes (57,1 por ciento) en hombres (80,6 por ciento) y de forma general también fue el sexo masculino el más afectado (68,3 por ciento). La mayoría de los pacientes que tuvieron tanto infartos medianos (59,3 por ciento) como infartos grandes (58,3 por ciento), refirieron de 3 a 4 factores de riesgo aterotrombótico (58,7 por ciento). Prevaleció la hipertensión arterial (82,5 por ciento), con mayor coincidencia con los infartos medianos (88,9 por ciento), que con los infartos grandes (77,8 por ciento). Conclusiones: El ictus aterotrombótico reciente de territorio de irrigación carotídeo se caracterizó en esta serie, por infartos grandes y mayor afectación de adultos mayores, hipertensos, del sexo masculino. La existencia de 3 a 4 factores de riesgo en cada paciente prevalece tanto en los que presentan infarto cerebral mediano como grande(AU)

Introduction: Most of atherothrombotic cerebral infarctions are due to extracranial atherosclerosis and the risk factors that condition it. Objective: To characterize patients with atherothrombotic stroke of the anterior territory according to size, sex and atherothrombotic risk factors. Method: A cross-sectional study was performed on 63 patients attended at the "Dr. Carlos J. Finlay" hospital with a diagnosis of recent atherothrombotic cerebral infarction of the carotid territory, who underwent simple skull tomography, between 2011 and 2013. Results: Large infarcts predominated (57.1 percent) in men (80.6 percent) and in general, male sex was also the most affected (68.3 percent). Most of patients who had both moderate infarcts (59.3 percent) and large infarcts (58.3 percent), reported 3 to 4 atherothrombotic risk factors (58.7 percent). Prevalence of arterial hypertension (82.5 percent), with greater coincidence with medium infarcts (88.9 percent), than with large infarcts (77.8 percent). Conclusions: The recent atherothrombotic stroke of the carotid irrigation area was characterized in this series, due to large infarcts and greater involvement of elderly, hypertensive males. The existence of 3 to 4 risk factors in each patient prevails both in those with medium cerebral infarction and large ones(AU)

Aterosclerosis carotídea en el infarto cerebral aterotrombótico del territorio vascular homónimo / Carotid atherosclerosis in atherothrombotic cerebral infarction of the homonymous vascular territory

Introducción: El eco-Doppler carotídeo es la prueba de elección en el estudio inicial y de seguimiento del ictus aterotrombótico. Objetivo: Describir los hallazgos ecográficos en ambos ejes carotídeos en pacientes con infarto cerebral aterotrombótico del territorio vascular homónimo. Métodos: Se realizó una investigación observacional con todos los pacientes (63), que acudieron al Hospital Militar Central "Dr. Carlos J. Finlay", entre octubre del 2012 y septiembre del 2013, con diagnóstico clínico y tomográfico de infarto cerebral aterotrombótico de territorio anterior, a los que se les realizó eco-Doppler carotídeo. Resultados: Se contabilizaron mayor cantidad de placas de ateromas en el eje carotídeo homolateral al ictus aterotrombótico (54,3 por ciento) y la gran mayoría de estos fueron inestables (98,4 por ciento). La placa tipo III (50 por ciento), la irregularidad del contorno (54,1 por ciento) y la estenosis menor del 49 por ciento (57,6 por ciento) fueron los hallazgos ecográficos que dominaron en el eje contralateral al infarto. En ambas carótidas también fueron las placas tipo III (47,1 por ciento), la irregularidad de los contornos (51,6 por ciento), las estenosis no significativas (54,3 por ciento) y la inestabilidad de estas (94,4 por ciento), las que predominaron. Conclusiones: La aterosclerosis carotídea en el ictus aterotrombótico describe mayoritariamente placas tipo III irregulares, que provocan estenosis menores del 49 por ciento en ambos ejes carotídeos y la inestabilidad es casi constante, con una incidencia ligeramente mayor en el eje carotídeo homolateral al infarto. La frecuencia del resto de las cualidades de las placas de ateromas enunciadas, domina levemente en el eje carotídeo contralateral(AU)

Introduction: Carotid echo-Doppler is the test of choice in the initial and follow-up study of atherothrombotic stroke. Objective: To describe echographic findings in both carotid axes in patients with atherothrombotic cerebral infarction of the homonymous vascular territory. Methods: Sixty-three patients underwent an observational and cross-sectional investigation at Dr. Carlos J. Finlay Central Military Hospital from October 2012 to September 2013. They have a clinical and tomographic diagnosis of atherothrombotic cerebral infarct from the previous territory and the underwent a carotid echo-Doppler. Results: We recorded higher number of atheromatous plaques in the homolateral carotid axis at atherothrombotic stroke (54.3 percent) and the majority was unstable (98.4 percent). Type III plate (50 percent), irregularity of the contour (54.1 percent) and less than 49 percent stenosis (57.6 percent) were the echographic findings that dominated the axis contralateral to the infarction. In both carotids, type III plaques (47.1 percent), irregularity of the contours (51.6 percent), non-significant stenosis (54.3 percent) and instability (94.4 percent) predominated. Conclusions: Carotid atherosclerosis in atherothrombotic stroke mostly describes the presence of irregular, type III plaques that cause stenosis of less than 49 percent in both carotid axes. The instability of them is almost constant, with a slightly higher incidence in the homolateral carotid axis to infarction. The frequency of the rest of the qualities of the listed atheromatous plaques slightly dominates in the contralateral carotid axis(AU)

The Levels of Hyperhomocystinemia and the Types of Ischemic Cerebrovascular Disease / 国际脑血管病杂志

Objective:To explore the relationship betwwen the different types of ischemic cerebrovascular disease andthe levels of plasma Homocystine(Hcy).Methods:The levels of plasma Hcy in 135 patients with ischemic cerebrovascular disease were measured by the fluorometric method.All the patients were divided into transient ischemic attack(TLA)group and atherothrombotic cerebral infarction(ACO group.The patients in both groups and the levels of plasma Hcy between the primary ACI and recurrent ACI were compared.Results:The levels of plasma Hcy in the ACI group(22.0±6.4 μmol/L)group were significantly higher than those in the TIA group(16.6±6.0 μmol/L)(P＜0.01),and the levels of plasma Hcy in the recurrent ACI group(23.0±5.5 5 μmol/L)were significantly higher than those in the primary group(19.6±5.9 μmol/L)(P＜0.01).There were rio significant differences between the two groups in age,sex,history of smoking.lipid,body mass index,as well as the prevalences of hypertension,diabetes mellitus and coronary heart disease.Conclusions:The increased level of plasma Hcy is closely associated with ACI.and it is a risk factor for recurrent stroke.

Aassociation between gene polymorphism of interleukin-4 C590T and serum level of interleukin-4 and atherothrombotic cerebral infarction / 临床神经病学杂志

Objective To explore the association between gene polymorphism of interleukin(IL)-4 C590T and serum level of IL-4 and atherothrombotic cerebral infarction(ATCI).Methods The gene polymorphisms of IL-4 C590T in 159 patients with ATCI and 151 normal control subjects were carried out by polymerase chain reaction(PCR)-restriction fragment length polymorphism(RFLP).The serum level of IL-4 in normal control group was determined with enzyme linked immunosorbent assay(ELISA) method.Results In the normal control group,the serum level of IL-4 in TT genotype[(31.85?5.68) pg/ml] was higher significantly than those in TC[(28.67?6.00) pg/ml] and CC genotypes[(20.98?0.99) pg/ml],TC genotype was higher significantly than CC genotype(all P0.05).Conclusions IL-4 590T allele is associated with higher level of serum IL-4.The C590T polymorphism is not associated with the incidence of ATCI.